Clinical Efficacy of Indapamide Combined with Benazepril in the Treatment of Hypertension Complicated with Heart Failure and its Influence on the Level of Vasoactive Substances in Patients
CAO Xuezeng, LIU Keliang
Sheqi Hospital of Traditional Chinese Medicine, Sheqi Henan 473300
Abstract：【Objective】To investigate the clinical efficacy of indapamide combined with benazepril in the treatment of hypertension complicated with heart failure and its influence on the level of vasoactive substances. 【Methods】A total of 108 patients with hypertension complicated with heart failure admitted to our hospital from March 2018 to January 2020 were selected and divided into observation group (indapamide combined with benazepril) and control group (hydrochlorothiazide combined with benazepril) according to the treatment method, with 54 cases in each group. The clinical efficacy, vasoactive substances [endothelin (ET), nitric oxide (NO), vasoactive peptide (Apelin), calcitonin gene-related peptide (CGRP)], cardiac function indexes [left ventricular end systolic diameter (LVESD), left ventricular ejection fraction (LVEF), N-terminal pro brain natriuretic peptide (NT-proBNP), left ventricular end diastolic diameter (LVEDD), and 6-min walking distance (6MWD)] were compared between the two groups, and the occurrence of adverse reactions was compared between the two groups. 【Results】After treatment, the clinical effective rate of the observation group was higher than that of the control group, and the difference was statistically significant (P<0.05). After treatment, the levels of serum CGRP, no and Apelin in the two groups were higher than those before treatment, and ET was lower than that before treatment. The levels of serum CGRP, no and Apelin in the observation group were higher than those in the control group, and ET was lower than that in the control group (P<0.05). After treatment, LVEF and 6MWD in the two groups were higher than before treatment, LVESD, LVEDD and NT-proBNP were lower than before treatment, LVEF and 6MWD in the observation group were higher than those in the control group, LVESD, LVEDD and NT-proBNP were lower than those in the control group (P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05).【Conclusion】Indapamide combined with benazepril has good clinical efficacy in the treatment of hypertension complicated with heart failure, which can improve cardiac function and regulate the expression of vasoactive substances.
曹学增, 刘柯良. 吲达帕胺联合贝那普利治疗高血压合并心力衰竭的临床疗效及其对患者血管活性物质水平的影响[J]. 医学临床研究, 2024, 41(9): 1343-1345.
CAO Xuezeng, LIU Keliang. Clinical Efficacy of Indapamide Combined with Benazepril in the Treatment of Hypertension Complicated with Heart Failure and its Influence on the Level of Vasoactive Substances in Patients. JOURNAL OF CLINICAL RESEARCH, 2024, 41(9): 1343-1345.
2024, Vol. 41 
